The results are definitely considerably superior to current...

The results are definitely considerably superior to current standard of care. There is a path to approval. They have about $3.4M cash at the beginning of quarter equivalent to the burn in last quarter. Plus $500K US promissory note which could be converted to shares on Nov 17 or later there is cash at least this quarter end plus. Hope they do only a small raise at this price and look for a path of approval now. Fingers crossed right moves will be moved.